202 MTOR PATHWAY IN PAPILLARY RENAL CELL CARCINOMA (PAPRCC): PROGNOSTIC ROLE AND POTENTIAL TARGET OF THERAPY

MLA

Angelo M. De Marzo, et al. “202 Mtor Pathway in Papillary Renal Cell Carcinoma (Paprcc): Prognostic Role and Potential Target of Therapy.” Journal of Urology, vol. 183, Apr. 2010. EBSCOhost, https://doi.org/10.1016/j.juro.2010.02.259.

APA

Angelo M. De Marzo, Roberto Pili, George J. Netto, Pedram Argani, Roula Albadine, Jessica Hicks, Victor E. Reuter, Luciana Schultz, & Michael A. Carducci. (2010). 202 Mtor Pathway in Papillary Renal Cell Carcinoma (Paprcc): Prognostic Role and Potential Target of Therapy. Journal of Urology, 183. https://doi.org/10.1016/j.juro.2010.02.259

Chicago

Angelo M. De Marzo, Roberto Pili, George J. Netto, Pedram Argani, Roula Albadine, Jessica Hicks, Victor E. Reuter, Luciana Schultz, and Michael A. Carducci. 2010. “202 Mtor Pathway in Papillary Renal Cell Carcinoma (Paprcc): Prognostic Role and Potential Target of Therapy.” Journal of Urology 183 (April). doi:10.1016/j.juro.2010.02.259.